These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 22777296

  • 1. Response to growth hormone therapy in children with Noonan syndrome: correlation with or without PTPN11 gene mutation.
    Choi JH, Lee BH, Jung CW, Kim YM, Jin HY, Kim JM, Kim GH, Hwang JS, Yang SW, Lee J, Yoo HW.
    Horm Res Paediatr; 2012; 77(6):388-93. PubMed ID: 22777296
    [Abstract] [Full Text] [Related]

  • 2. Long-term GH treatment improves adult height in children with Noonan syndrome with and without mutations in protein tyrosine phosphatase, non-receptor-type 11.
    Noordam C, Peer PG, Francois I, De Schepper J, van den Burgt I, Otten BJ.
    Eur J Endocrinol; 2008 Sep; 159(3):203-8. PubMed ID: 18562489
    [Abstract] [Full Text] [Related]

  • 3. PTPN11 (protein tyrosine phosphatase, nonreceptor type 11) mutations and response to growth hormone therapy in children with Noonan syndrome.
    Ferreira LV, Souza SA, Arnhold IJ, Mendonca BB, Jorge AA.
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5156-60. PubMed ID: 15956085
    [Abstract] [Full Text] [Related]

  • 4. PTPN11 mutations are associated with mild growth hormone resistance in individuals with Noonan syndrome.
    Binder G, Neuer K, Ranke MB, Wittekindt NE.
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5377-81. PubMed ID: 15985475
    [Abstract] [Full Text] [Related]

  • 5. Response to growth hormone in short children with Noonan syndrome: correlation to genotype.
    Binder G.
    Horm Res; 2009 Dec; 72 Suppl 2():52-6. PubMed ID: 20029239
    [Abstract] [Full Text] [Related]

  • 6. Impact of Growth Hormone Therapy on Adult Height in Patients with PTPN11 Mutations Related to Noonan Syndrome.
    Malaquias AC, Noronha RM, Souza TTO, Homma TK, Funari MFA, Yamamoto GL, Silva FV, Moraes MB, Honjo RS, Kim CA, Nesi-França S, Carvalho JAR, Quedas EPS, Bertola DR, Jorge AAL.
    Horm Res Paediatr; 2019 Dec; 91(4):252-261. PubMed ID: 31132774
    [Abstract] [Full Text] [Related]

  • 7. Five-year response to growth hormone in children with Noonan syndrome and growth hormone deficiency.
    Zavras N, Meazza C, Pilotta A, Gertosio C, Pagani S, Tinelli C, Bozzola M.
    Ital J Pediatr; 2015 Oct 06; 41():71. PubMed ID: 26444854
    [Abstract] [Full Text] [Related]

  • 8. [Phenotype variability in Noonan syndrome patients with and without PTPN11 mutation].
    Ferreira LV, Souza SA, Montenegro LR, Arnhold IJ, Pasqualini T, Heinrich JJ, Keselman AC, Mendonça BB, Jorge AA.
    Arq Bras Endocrinol Metabol; 2007 Apr 06; 51(3):450-6. PubMed ID: 17546245
    [Abstract] [Full Text] [Related]

  • 9. Noonan syndrome: rhGH treatment and PTPN11 mutation.
    Wu X, Wu J, Yuan Y, Yang L, Yu L.
    Mol Genet Genomic Med; 2023 Nov 06; 11(11):e2266. PubMed ID: 37525886
    [Abstract] [Full Text] [Related]

  • 10. GH therapy in Noonan syndrome: Review of final height data.
    Dahlgren J.
    Horm Res; 2009 Dec 06; 72 Suppl 2():46-8. PubMed ID: 20029237
    [Abstract] [Full Text] [Related]

  • 11. Noonan syndrome: growth to growth hormone - the experience of observational studies.
    Ranke MB.
    Horm Res; 2009 Dec 06; 72 Suppl 2():36-40. PubMed ID: 20029235
    [Abstract] [Full Text] [Related]

  • 12. The short-term effects of growth hormone therapy on height velocity and cardiac ventricular wall thickness in children with Noonan's syndrome.
    Cotterill AM, McKenna WJ, Brady AF, Sharland M, Elsawi M, Yamada M, Camacho-Hübner C, Kelnar CJ, Dunger DB, Patton MA, Savage MO.
    J Clin Endocrinol Metab; 1996 Jun 06; 81(6):2291-7. PubMed ID: 8964866
    [Abstract] [Full Text] [Related]

  • 13. Noonan syndrome: relationships between genotype, growth, and growth factors.
    Limal JM, Parfait B, Cabrol S, Bonnet D, Leheup B, Lyonnet S, Vidaud M, Le Bouc Y.
    J Clin Endocrinol Metab; 2006 Jan 06; 91(1):300-6. PubMed ID: 16263833
    [Abstract] [Full Text] [Related]

  • 14. Growth response, near-adult height, and patterns of growth and puberty in patients with noonan syndrome treated with growth hormone.
    Romano AA, Dana K, Bakker B, Davis DA, Hunold JJ, Jacobs J, Lippe B.
    J Clin Endocrinol Metab; 2009 Jul 06; 94(7):2338-44. PubMed ID: 19401366
    [Abstract] [Full Text] [Related]

  • 15. Abnormal growth in noonan syndrome: genetic and endocrine features and optimal treatment.
    Padidela R, Camacho-Hübner C, Attie KM, Savage MO.
    Horm Res; 2008 Jul 06; 70(3):129-36. PubMed ID: 18663312
    [Abstract] [Full Text] [Related]

  • 16. IGF-I generation test in prepubertal children with Noonan syndrome due to mutations in the PTPN11 gene.
    Bertelloni S, Baroncelli GI, Dati E, Ghione S, Baldinotti F, Toschi B, Simi P.
    Hormones (Athens); 2013 Jul 06; 12(1):86-92. PubMed ID: 23624134
    [Abstract] [Full Text] [Related]

  • 17. Analysis of the PTPN11 gene in idiopathic short stature children and Noonan syndrome patients.
    Ferreira LV, Souza SC, Montenegro LR, Malaquias AC, Arnhold IJ, Mendonca BB, Jorge AA.
    Clin Endocrinol (Oxf); 2008 Sep 06; 69(3):426-31. PubMed ID: 18331608
    [Abstract] [Full Text] [Related]

  • 18. PTPN11 and KRAS gene analysis in patients with Noonan and Noonan-like syndromes.
    Brasil AS, Pereira AC, Wanderley LT, Kim CA, Malaquias AC, Jorge AA, Krieger JE, Bertola DR.
    Genet Test Mol Biomarkers; 2010 Jun 06; 14(3):425-32. PubMed ID: 20578946
    [Abstract] [Full Text] [Related]

  • 19. Abnormal growth in noonan syndrome: the challenge of optimal therapy.
    Savage MO, Padidela R, Kirk JM, Malaquias AC, Jorge AA.
    Pediatr Endocrinol Rev; 2009 Jun 06; 6 Suppl 4():523-8. PubMed ID: 19550387
    [Abstract] [Full Text] [Related]

  • 20. [Noonan syndrome: from phenotype to growth hormone therapy].
    Malaquias AC, Ferreira LV, Souza SC, Arnhold IJ, Mendonça BB, Jorge AA.
    Arq Bras Endocrinol Metabol; 2008 Jul 06; 52(5):800-8. PubMed ID: 18797587
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.